QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
NASDAQ:ADUS

Addus HomeCare Stock Forecast, Price & News

$85.83
+2.81 (+3.38 %)
(As of 09/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$82.88
$86.86
50-Day Range
$82.64
$94.70
52-Week Range
$80.32
$129.01
Volume89,172 shs
Average Volume100,146 shs
Market Capitalization$1.37 billion
P/E Ratio36.22
Dividend YieldN/A
Beta0.72
30 days | 90 days | 365 days | Advanced Chart
Receive ADUS News and Ratings via Email

Sign-up to receive the latest news and ratings for Addus HomeCare and its competitors with MarketBeat's FREE daily newsletter.


Addus HomeCare logo

About Addus HomeCare

Addus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The Hospice segment includes physical, emotional, and spiritual care for people who are terminally ill as well as for their families. The Home Health segment offers services that are primarily medical in nature to individuals who may require assistance during an illness or after surgery, and include skilled nursing and physical, occupational and speech therapy. The company was founded on July 27, 2006 and is headquartered in Frisco, TX.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Home health care services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ADUS
Employees
20,583
Year Founded
N/A

Sales & Book Value

Annual Sales
$764.78 million
Cash Flow
$3.59 per share
Book Value
$32.81 per share

Profitability

Net Income
$33.13 million

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$1.37 billion
Next Earnings Date
11/1/2021 (Estimated)
Optionable
Optionable

MarketRank

Overall MarketRank

2.45 out of 5 stars

Medical Sector

143rd out of 1,353 stocks

Home Health Care Services Industry

5th out of 10 stocks

Analyst Opinion: 3.5Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -












Addus HomeCare (NASDAQ:ADUS) Frequently Asked Questions

Is Addus HomeCare a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Addus HomeCare in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Addus HomeCare stock.
View analyst ratings for Addus HomeCare
or view top-rated stocks.

What stocks does MarketBeat like better than Addus HomeCare?

Wall Street analysts have given Addus HomeCare a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Addus HomeCare wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Addus HomeCare's next earnings date?

Addus HomeCare is scheduled to release its next quarterly earnings announcement on Monday, November 1st 2021.
View our earnings forecast for Addus HomeCare
.

How were Addus HomeCare's earnings last quarter?

Addus HomeCare Co. (NASDAQ:ADUS) issued its quarterly earnings data on Sunday, August, 1st. The company reported $0.90 EPS for the quarter, beating analysts' consensus estimates of $0.89 by $0.01. The company earned $217.90 million during the quarter, compared to the consensus estimate of $216.79 million. Addus HomeCare had a trailing twelve-month return on equity of 8.62% and a net margin of 4.68%. The business's revenue was up 18.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.73 earnings per share.
View Addus HomeCare's earnings history
.

How has Addus HomeCare's stock price been impacted by COVID-19?

Addus HomeCare's stock was trading at $67.64 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ADUS shares have increased by 26.9% and is now trading at $85.83.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for ADUS?

2 brokerages have issued 1-year price objectives for Addus HomeCare's shares. Their forecasts range from $115.00 to $115.00. On average, they anticipate Addus HomeCare's share price to reach $115.00 in the next year. This suggests a possible upside of 34.0% from the stock's current price.
View analysts' price targets for Addus HomeCare
or view top-rated stocks among Wall Street analysts.

Who are Addus HomeCare's key executives?

Addus HomeCare's management team includes the following people:

What is Dirk Allison's approval rating as Addus HomeCare's CEO?

91 employees have rated Addus HomeCare CEO Dirk Allison on Glassdoor.com. Dirk Allison has an approval rating of 51% among Addus HomeCare's employees. This puts Dirk Allison in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Addus HomeCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Addus HomeCare investors own include AbbVie (ABBV), Bank of America (BAC), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Verizon Communications (VZ), CVS Health (CVS), Pfizer (PFE), Ulta Beauty (ULTA), Cisco Systems (CSCO) and The Walt Disney (DIS).

What is Addus HomeCare's stock symbol?

Addus HomeCare trades on the NASDAQ under the ticker symbol "ADUS."

Who are Addus HomeCare's major shareholders?

Addus HomeCare's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (15.44%), Vanguard Group Inc. (6.41%), Dimensional Fund Advisors LP (3.52%), State Street Corp (3.17%), Wasatch Advisors Inc. (3.08%) and TimesSquare Capital Management LLC (3.04%). Company insiders that own Addus HomeCare stock include Brian Poff, Darby Anderson, David W Tucker, Laurie Manning, Mark L First, Michael D Wattenbarger, R Dirk Allison, Sean Gaffney, Susan T Weaver and W Bradley Bickham.
View institutional ownership trends for Addus HomeCare
.

Which institutional investors are selling Addus HomeCare stock?

ADUS stock was sold by a variety of institutional investors in the last quarter, including Royal Bank of Canada, Marshall Wace North America L.P., Wells Fargo & Company MN, Marshall Wace LLP, Marshall Wace LLP, Federated Hermes Inc., Tygh Capital Management Inc., and Bank of America Corp DE. Company insiders that have sold Addus HomeCare company stock in the last year include Brian Poff, David W Tucker, Laurie Manning, Mark L First, Michael D Wattenbarger, R Dirk Allison, Sean Gaffney, and W Bradley Bickham.
View insider buying and selling activity for Addus HomeCare
or view top insider-selling stocks.

Which institutional investors are buying Addus HomeCare stock?

ADUS stock was acquired by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., Kennedy Capital Management Inc., WCM Investment Management LLC, TimesSquare Capital Management LLC, Renaissance Technologies LLC, Principal Financial Group Inc., Morgan Stanley, and Morgan Stanley.
View insider buying and selling activity for Addus HomeCare
or or view top insider-buying stocks.

How do I buy shares of Addus HomeCare?

Shares of ADUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Addus HomeCare's stock price today?

One share of ADUS stock can currently be purchased for approximately $85.83.

How much money does Addus HomeCare make?

Addus HomeCare has a market capitalization of $1.37 billion and generates $764.78 million in revenue each year. The company earns $33.13 million in net income (profit) each year or $2.79 on an earnings per share basis.

How many employees does Addus HomeCare have?

Addus HomeCare employs 20,583 workers across the globe.

What is Addus HomeCare's official website?

The official website for Addus HomeCare is www.addus.com.

Where are Addus HomeCare's headquarters?

Addus HomeCare is headquartered at 6801 GAYLORD PARKWAY, FRISCO TX, 75034.

How can I contact Addus HomeCare?

Addus HomeCare's mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The company can be reached via phone at (469) 535-8200 or via email at [email protected].


This page was last updated on 9/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.